about
Antiangiogenic Therapy for Diabetic Nephropathy.Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model.Endogenous Antiangiogenic Factors in Chronic Kidney Disease: Potential Biomarkers of ProgressionRenal expression of trefoil factor 3 mRNA in association with tubulointerstitial fibrosis in IgA nephropathyTargeting angiogenesis and lymphangiogenesis in kidney diseaseRenal tubular injury exacerbated by vasohibin-1 deficiency in a murine cisplatin-induced acute kidney injury modelUrine 5MedC, a Marker of DNA Methylation, in the Progression of Chronic Kidney DiseaseCapnocytophaga canimorsus peritonitis diagnosed by mass spectrometry in a diabetic patient undergoing peritoneal dialysis: a case reportPodocyte autophagy is associated with foot process effacement and proteinuria in patients with minimal change nephrotic syndrome
P50
Q41403094-4A9DBE7E-9090-4BA0-8449-FAC16A7A9692Q52594144-64651FCF-126F-4095-BE48-D296113E93F8Q89224593-498E3BA9-2272-43F7-9FBD-16B9D58DE8F5Q89484845-12369821-0471-4D79-87E3-398A2E23F851Q90119264-2A1C955F-998E-4712-81AA-1F9E0C86F655Q92038413-63F12F65-54BE-4682-98CD-9687449C1B00Q92241121-0537A28D-739E-4AEC-AF79-768A2A85D9ADQ92756933-742D3156-8319-4493-9D26-4E33689CBF33Q92915243-4F91C544-51A1-40AA-B6A4-954187B8C092
P50
description
researcher
@en
wetenschapper
@nl
name
Katsuyuki Tanabe
@en
Katsuyuki Tanabe
@nl
type
label
Katsuyuki Tanabe
@en
Katsuyuki Tanabe
@nl
prefLabel
Katsuyuki Tanabe
@en
Katsuyuki Tanabe
@nl
P31
P496
0000-0003-4767-5892